Selective serotonin reuptake inhibitors in depression: An editorial review

Abstract

Depression is a prevalent mental health disorder characterized by persistent feelings of sadness, loss of interest, and a range of emotional and physical problems. According to the World Health Organization, depression affects over 264 million people globally, making it a leading cause of disability worldwide. The disorder can severely impact daily functioning and quality of life, necessitating effective treatment strategies.